Albert Einstein College of Medicine

The Albert Einstein College of Medicine, which is part of Montefiore Medicine, is a premier biomedical research institution with approximately $200 million in funding from the National Institutes of Health. Montefiore Medicine brings together the clinical, scientific, and educational enterprises of the Montefiore Health System and the Albert Einstein College of Medicine. This organizational structure leverages the strengths of experienced academic and healthcare leadership and facilitates collaborations between the two entities in basic, clinical, and translational research.

Einstein has a comprehensive scientific infrastructure that enhances opportunities for research. The campus encompasses ~1 million sq ft of space for 300 laboratories and offices and houses several NIH-designated centers and centers of excellence. These include the Montefiore Einstein Comprehensive Cancer Center, the Diabetes Research Center, the New York Regional Center for Diabetes Translation Research, the Harold and Muriel Block Institute for Clinical and Translational Research, the Einstein-Rockefeller-CUNY Center for AIDS Research, the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center, and the Institute for Aging Research. 

Einstein is home to more than 1,900 full-time faculty members, 740 M.D. students, 194 Ph.D. students, 118 students in the combined M.D./Ph.D. program, and 235 postdoctoral fellows at the Belfer Institute for Advanced Biomedical Studies. With over 9,000 alumni, Einstein has produced leading clinicians, biomedical scientists, and medical educators across the country. Einstein’s major research centers focus on cancer, aging, intellectual development disorders, diabetes, clinical and translational research, and AIDS. Additional areas of expertise include developmental brain research, neuroscience, and cardiac disease. Through its partnership with Montefiore, Einstein maintains a strong emphasis on bench-to-bedside research, translating laboratory discoveries into treatments and therapies that directly benefit patients.